Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

The abstract is available on the ObesityWeek website and can be accessed directly here. About Diazoxide Choline Controlled-Release (DCCR) TabletDiazoxide Choline Controlled-Release tablet is a novel, ...

Please provide your email address to receive an email when new articles are posted on . Two presentations at the 2018 Foundation for Prader-Willi Research Annual Conference in Las Vegas detailed ...

A slow-release, tablet form of ketamine with minimal side-effects has the potential to make treatment more affordable and accessible. A new tablet form of ketamine has shown promise in treating severe ...